This website uses technical, customisation and analytical cookies, both first-party and third-party, to anonymously facilitate browsing and analyse statistics on use of the website. Learn more
Search results
-
Philips NV: Dealing with a Global Financial Crisis
Christopher Williams; Ramasastry ChandrasekharCase IVEY-9B13M011-EStrategyPhilips NV, a multinational organization based in the Netherlands, is facing strategic dilemmas. The company has been in the middle of a transformation involving a shift in focus from lighting and health care products towards consumer products and services when a financial meltdown, triggered by a crisis in the U.S. housing market, leads to a credit crunch in financial markets. Countries that have traditionally sustained the demand for Philips me...Starting at €8.20
-
Boehringer Ingelheim: Leading Innovation
J. Robert Mitchell; Ramasastry ChandrasekharCase IVEY-9B14M168-EEntrepreneurship, StrategyThe newly appointed director of Innovation Management & Strategy at Boehringer Ingelheim, a German-based multinational pharmaceutical company, is finding his way forward in his firm’s new, first-of-its-kind role, which is central to the company’s growth rejuvenation strategy. His job has a threefold mandate: to build internal networks, to establish internal structures and to leverage internal ideas. His biggest challenge, however, may be transfor...Starting at €8.20
-
Dr. Reddy's Laboratories (B)
Jean-Louis Schaan; Ramasastry ChandrasekharCase IVEY-9B08M065-EStrategyThis supplement to Dr. Reddy's Laboratories (A), product # 9B08M064, looks at the two years post-acquisition and examines a major risk which, as it unfolded, brought the viability of the business model into question.Starting at €5.74
-
Dr. Reddy's Laboratories (A)
Jean-Louis Schaan; Ramasastry ChandrasekharCase IVEY-9B08M064-EStrategyDr. Reddy's Laboratories (Dr. Reddy's), a large pharmaceutical company in India, is trying to acquire the fourth largest generics manufacturer in Germany. Dr. Reddy's quoted $570 million in a competitive bidding situation. The company's chief negotiator is getting ready to close the deal if selected. Students will examine the issues for the chief negotiator, such as: is the price right, is the fit strategic, will the acquisition add value, how ca...Starting at €8.20
-
Intrapreneurship at Alcatel-Lucent
Simon Parker; Ramasastry ChandrasekharCase IVEY-9B14M169-EEntrepreneurship, StrategySince 2006, Alcatel-Lucent, an international telecommunications equipment manufacturer based in Paris, France, has been conducting boot camps for its employees to provide business training and help them monetize their innovative ideas with a view to creating value for the company. The program has led to 32 projects of which two have been commercialized, three transferred to business units within Alcatel-Lucent and one spun off. In 2012, however, ...Starting at €8.20
-
Volkswagen Strategy 2025: Shifting Gears in Disruptive Times
Andreas Schotter; Thomas Watson; Ramasastry ChandrasekharCase IVEY-9B19M047-EStrategyIn 2018, Volkswagen Group’s newly appointed chief executive officer renewed the company’s commitment to Strategy 2025, an ongoing plan intended to radically transform the German automaker. Volkswagen was being challenged by tectonic changes in the automotive industry, including the phasing out of the long-standing internal combustion engine, ongoing digitization, the entry of new competition from technology companies, the introduction of electric...Starting at €8.20
-
Dr. Reddy's Laboratories (A) (Spanish version)
Jean-Louis Schaan; Ramasastry ChandrasekharCase IVEY-9B08MS64StrategyDr. Reddy's Laboratories (Dr. Reddy's), a large pharmaceutical company in India, is trying to acquire the fourth largest generics manufacturer in Germany. Dr. Reddy's quoted $570 million in a competitive bidding situation. The company's chief negotiator is getting ready to close the deal if selected. Students will examine the issues for the chief negotiator, such as: is the price right, is the fit strategic, will the acquisition add value, how ca...Starting at €8.20
-
Dr. Reddy's Laboratories (B) (Spanish version)
Jean-Louis Schaan; Ramasastry ChandrasekharCase IVEY-9B08MS65StrategyThis supplement to Dr. Reddy's Laboratories (A), product # 9B08M064, looks at the two years post-acquisition and examines a major risk which, as it unfolded, brought the viability of the business model into question.Starting at €5.74
-
Johnson Controls International Plc: Managing Strategic Accounts
Michael Taylor; Ramasastry ChandrasekharCase IVEY-W25578-EMarketing, StrategyThe chief commercial officer of Johnson Controls International, a multinational manufacturer and marketer of security systems, was noticing a change in the buying behaviour of one of its premier customers. As one of the company’s designated strategic accounts, this customer was entitled to multi-level collaborative support. Of late, the customer had been taking a “bid-and-buy” approach to its purchases, ignoring the standards agreed to in the str...Starting at €8.20